INBIONET, acronym standing for “INfection BIOlogy Training NETwork”, at the interface between microbiology, immunology and cellular biology, aims to explore some of the most novel themes that are beginning to emerge in the mechanisms by which pathogens manipulate host defence responses. Further, it is expected that this knowledge will lead to the development of innovative therapies based on the modulation of the host-pathogen interface.


The project is funded under the Marie Curie Initial Training Network scheme (ITN) as part of the EU’s Seventh Framework Programme (FP7) and will run from the 1st of January 2013 to 31st of December 2016. During the 4-year duration of the project a total of 15 fellows will receive training in all areas of infection biology research.


The Network integrates seven academic groups internationally recognized in the fields of microbial pathogenesis, innate immunity and molecular recognition, and intensive research SME, Preclin Biosystems, a multinational pharmaceutical company, Sanofi-Aventis, and is further supported by one associated partner (ParcBit, technological part).

Outreach & News

How viruses help us understand the way our immune system works

Jana Musilova explains the way in which viruses can give us a greater understanding of how our immune systems works.

Read more

Macrophages: Butlers of Homeostasis

In his latest report Marton Janos considers the diverse functions of macrophages beyond their classical role as anti-microbial phagocytes.


Read more

Joint INBIONET/Infect-ERA Conference success



100 international delegates came together for this 2 day event held at Queen's University Belfast.

Read more

Queen’s University Belfast to host joint INBIONET/Infect-ERA Conference over 14-15th September 2016


This exciting event will be the first time that these
two initiatives will meet and is the ideal forum
for these projects to present and discuss results
and initiate new ideas and collaborations. 
For programme details please click here.

Read more